Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress
11 oct. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foralumab): Safety, Biomarker, And Disability Outcomes
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
08 sept. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunology
23 août 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Dr. Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Thursday, August 17th at 4:00 pm ET
15 août 2023 16h01 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Dr. Patrick Gruber, Chief Executive Officer, will participate in a Water Tower Research Fireside...
FRO – Q1 2023 Presentation
31 mai 2023 08h49 HE
|
Frontline plc.
Please find enclosed the presentation of Frontline plc´s first quarter 2023 results to be held on the webcast / conference call 31 May, 2023 at 15:00 CET. This information is subject to the...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Jefferies Healthcare Conference
25 mai 2023 17h15 HE
|
Mettler-Toledo, LLC
Columbus, OH, May 25, 2023 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Jefferies Healthcare Conference on Thursday, June...
Hillman Announces Participation at Upcoming Investor Conferences During June 2023
23 mai 2023 07h30 HE
|
The Hillman Group
CINCINNATI, May 23, 2023 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, today announced...
Tiziana Life Sciences Announces Chief Medical Officer Invited to Give Presentation on Intranasal Foralumab on May 17
17 mai 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, May 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Clear Communication Academy Launches New Intensive Presentation Training Program
05 mai 2023 09h00 HE
|
Clear Communication Academy
Studio City, CA, May 05, 2023 (GLOBE NEWSWIRE) -- Clear Communication Academy has recently announced the launch of its intensive Presentation Training Program customized for those who want to take...
OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023
03 mai 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...